Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine

Succimer

Drug class: Lead Chelator

The FDA’s “Established Pharmacologic Class”: the group of medicines that work in a similar way.

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Succimer used for?
The FDA-approved label (Chemet, Recordati Rare Diseases, Inc., July 10, 2025) says: “CHEMET is indicated for the treatment of lead poisoning in pediatric patients aged 1 year and older with blood lead levels above 45 mcg/dL. CHEMET is a lead chelator indicated for the treatment of lead poisoning in pediatric patients aged 1 year and older with blood lead levels above 45 mcg/dL. Limitations of Use CHEMET is not indicated for prophylaxis of lead poisoning in a lead-containing environment. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Succimer have a boxed warning?
No. None of the 2 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Succimer?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Succimer been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Succimer?
2 companies list prescription products of Succimer in the FDA NDC Directory, including Recordati Rare Diseases, Inc. and Theragnostics Inc.

What Succimer is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

CHEMET is indicated for the treatment of lead poisoning in pediatric patients aged 1 year and older with blood lead levels above 45 mcg/dL. CHEMET is a lead chelator indicated for the treatment of lead poisoning in pediatric patients aged 1 year and older with blood lead levels above 45 mcg/dL. Limitations of Use CHEMET is not indicated for prophylaxis of lead poisoning in a lead-containing environment. …

— FDA label: Chemet, Recordati Rare Diseases, Inc., effective July 10, 2025. Read the full label on DailyMed →

The FDA has 2 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 2 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsCapsule · Injection, powder, lyophilized, for solution
RouteOral · Intravenous
Prescription products2 in the FDA NDC Directory
Brand namesChemet, Nephroscan

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA019998
CHEMET
Recordati RareJanuary 30, 1991 16, latest September 16, 2024
2024: Labeling · 2018: Labeling · 2016: Manufacturing (CMC)
NDA214993
NEPHROSCAN
TheragnosticsFebruary 18, 2022 —

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)198227, 207949
SPL set ID of the quoted label62035612-9505-3a3f-1ac8-e2dbd711d24e
FDA labels (SPL)2
FDA applicationsNDA019998, NDA214993
Active ingredients (FDA)SUCCIMER

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Chemet, Recordati Rare Diseases, Inc., effective July 10, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers